Morphine as a treatment of cancer-induced pain—is it safe? A review of in vivo studies and mechanisms
- 127 Downloads
Morphine has been used in the treatment of pain for centuries. It is commonly used by oncology in terminal cancer cases and by surgery perioperatively for oncology surgery. Its extra-analgesic effects on cancer have been described extensively but conflicting results abound. It has been shown to have varying effects on tumour progression, cell proliferation, tumour invasion, angiogenesis, immune function, and metastatic potential. In vivo studies on the effects of morphine and the mu-opioid receptor on tumours are discussed below. Mechanisms involved are also discussed, drawn from a combination of both in vivo and in vitro methods. At present, no consensus can be drawn from data collected, and further studies are necessary to elicit the safest method and agent for analgesia in oncology patients.
KeywordsMorphine In vivo Cancer Mu-opioid receptor
DB conceived, researched, and wrote the manuscript. All authors read and approved the manuscript.
- Balasubramanian S, Ramakrishnan S, Charboneau R, Wang J, Barke RA, Roy S (2001) Morphine sulfate inhibits hypoxia-induced vascular endothelial growth factor expression in endothelial cells and cardiac myocytes. J Mol Cell Cardiol 33:2179–2187. https://doi.org/10.1006/jmcc.2001.1480 CrossRefPubMedGoogle Scholar
- Doornebal CW, Vrijland K, Hau CS, Coffelt SB, Ciampricotti M, Jonkers J, de Visser KE, Hollmann MW (2015) Morphine does not facilitate breast cancer progression in two preclinical mouse models for human invasive lobular and HER2(+) breast cancer. Pain 156:1424–1432. https://doi.org/10.1097/j.pain.0000000000000136 CrossRefPubMedGoogle Scholar
- Farooqui M, Li Y, Rogers T, Poonawala T, Griffin RJ, Song CW, Gupta K (2007) COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer 97:1523–1531. https://doi.org/10.1038/sj.bjc.6604057 CrossRefPubMedPubMedCentralGoogle Scholar
- Gach K, Szemraj J, Fichna J, Piestrzeniewicz M, Delbro DS, Janecka A (2009) The influence of opioids on urokinase plasminogen activator on protein and mRNA level in MCF-7 breast cancer cell line. Chem Biol Drug Des 74:390–396. https://doi.org/10.1111/j.1747-0285.2009.00875.x CrossRefPubMedGoogle Scholar
- Hutchinson MR, Zhang Y, Shridhar M, Evans JH, Buchanan MM, Zhao TX, Slivka PF, Coats BD, Rezvani N, Wieseler J, Hughes TS, Landgraf KE, Chan S, Fong S, Phipps S, Falke JJ, Leinwand LA, Maier SF, Yin H, Rice KC, Watkins LR (2010) Evidence that opioids may have toll like receptor 4 and MD-2 effects. Brain Behav Immun 24:83–95. https://doi.org/10.1016/j.bbi.2009.08.004 CrossRefPubMedGoogle Scholar
- Kalvass JC, Olson ER, Cassidy MP, Selley DE, Pollack GM (2007) Pharmacokinetics and pharmacodynamics of seven opioids in P-glycoprotein-competent mice: assessment of unbound brain EC50,u and correlation of in vitro, preclinical, and clinical data. J Pharmacol Exp Ther 323:346–355. https://doi.org/10.1124/jpet.107.119560 CrossRefPubMedGoogle Scholar
- Koodie L, Yuan H, Pumper JA, Yu H, Charboneau R, Ramkrishnan S, Roy S (2014) Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice. Am J Pathol 184:1073–1084. https://doi.org/10.1016/j.ajpath.2013.12.019 CrossRefPubMedPubMedCentralGoogle Scholar
- Lennon FE, Mirzapoiazova T, Mambetsariev B, Salgia R, Moss J, Singleton PA (2012) Overexpression of the mu-opioid receptor in human non-small cell lung cancer promotes Akt and mTOR activation, tumor growth, and metastasis. Anesthesiology 116:857–867. https://doi.org/10.1097/ALN.0b013e31824babe2 CrossRefPubMedGoogle Scholar
- Nguyen J, Luk K, Vang D, Soto W, Vincent L, Robiner S, Saavedra R, Li Y, Gupta P, Gupta K (2014) Morphine stimulates cancer progression and mast cell activation and impairs survival in transgenic mice with breast cancer. BJA: British J Anaesthesia 113:i4–i13. https://doi.org/10.1093/bja/aeu090 CrossRefGoogle Scholar